Abstract
Objective: To describe a case of rapidly progressive pulmonary vasculitis, difficult to diagnose and manage therapeutically, in a previously healthy patient, whose autoimmune nature was confirmed by the positivity of anticitrulline antibody and antinuclear factor. Case Details: Patient, 34 years old, female, on the fifth day postpartum with fetal death, presenting with polyarthritis and fever syndrome, with elevated inflammatory markers, negative autoimmune panel, except for ANA and Anti-CCP, which progressed to Severe Acute Respiratory Distress Syndrome, requiring mechanical ventilation, unresponsive to pulse therapy with methylprednisolone and intravenous cyclophosphamide, and successful therapeutic outcome with Rituximab. Final Considerations: Anti-CCP positive pulmonary vasculitis, also called rheumatoid, is a rare complication, with no well-defined diagnostic criteria and no well-described treatment in the literature. For this reason, it is essential to share experiences regarding the diagnosis and management of non-ANCA-associated pulmonary vasculitis to contribute to improving the approach to similar cases and enrich the literature on the subject.
References
ADAMS TN, et al. Pulmonary manifestations of large, medium, and variable vessel vasculitis. Respiratory Medicine, 2018; 145: 182-191.
ANICETO L, et al. Abordagem terapêutica das vasculites pulmonares. Pulmão RJ, 2014; 23(2): 27-31.
BARBAS CSV, et al. Vasculites Pulmonares: Quando suspeitar e como fazer o diagnóstico. Jornal Brasileiro de Pneumologia, 2005; 31(1): 4-8.
CASAL A, et al. Pulmonary vasculitis. Journal of Thoracic Disease, 2018; 10(9): 5560-5575.
COSTA AN, et al. Doenças Intersticiais Pulmonares Associadas a Doenças do Tecido Conjuntivo. Pulmão RJ, 2013; 22(1): 26-32.
FIGUS FA, et al. Rheumatoid arthritis: Extra-articular manifestations and comorbidities. Autoimmunity Reviews, 2021; 20(4).
HOFFMAN GS e CALABRESE LH. Vasculitis: determinants of disease patterns. Nature Reviews Rheumatology, 2014; 10(8): 454-462.
JENNETTE JC, et al. 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis & Rheumatism, 2012; 65(1): 1–11.
JONES RB, et al. Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis. New England Journal of Medicine, 2010; 363(3): 211–220.
MAKOL A, et al. Vasculitis associated with rheumatoid arthritis: a case-control study. Rheumatology, 2014; 53(5): 890–899.
MARTINEZ JAB. Comprometimento pulmonar na artrite reumatoide. Revista Brasileira de Reumatologia, 2011; 51(4): 297 – 298.
MOTA LMH, et al. Diretrizes para o diagnóstico da artrite reumatoide. Revista Brasileira de Reumatologia, 2013; 53: 141–157.
MUKHTYAR C, et al. EULAR recommendations for the management of primary small and medium vessel vasculitis. Annals of the Rheumatic Diseases, 2009; 68(3): 310–317.
NASCIMENTO AF. Vasculites Pulmonares: Achados Histológicos e Diagnóstico Diferencial. Pulmão RJ, 2014; 23(2): 22-26.
NILES JL, et al. The syndrome of lung hemorrhage and nephritis is usually an ANCA-associated condition. Archives of Internal Medicine, 1996; 156(4): 440-445.
QUELUZ TT e Yoo HHB. Vasculites pulmonares: novas visões de uma velha conhecida. Jornal Brasileiro de Pneumologia, 2005; 31.
RAFFRAY L e GUILLEVIN L. Rituximab treatment of ANCA-associated vasculitis. Expert Opinion on Biological Therapy, 2020; 20(8): 899-910.
RAO JK. Limitations of the 1990 American College of Rheumatology Classification Criteria in the Diagnosis of Vasculitis. Annals of Internal Medicine, 1998; 129(5): 345.
ROBINSON CC, et al. Qualidade de vida pós-unidades de terapia intensiva: protocolo de estudo de coorte multicêntrico para avaliação de desfechos em longo prazo em sobreviventes de internação em unidades de terapia intensiva brasileiras. Revista Brasileira de Terapia Intensiva, 2019; 30: 405–413.
SANTANA FS, et al. Avaliação da capacidade funcional em pacientes com artrite reumatoide: implicações para a recomendação de exercícios físicos. Revista Brasileira de Reumatologia, 2014; 54(5): 378–385.
SILVA CIS e MÜLLER NL. Manifestações intratorácicas das doenças do colágeno na tomografia computadorizada de alta resolução do tórax. Publicação Científica Oficial do Colégio Brasileiro de Radiologia, 2008; 41(3): 189–197.
SPECKS U, et al. Efficacy of Remission-Induction Regimens for ANCA-Associated Vasculitis. New England Journal of Medicine, 2013; 369(5): 417–427.
SUNDERKÖTTEN CH, et al. Nomenclature of Cutaneous Vasculitis. Arthritis & Reumatology, 2018; 70(2): 171-184.
TAKANASHI S, et al. Effectiveness and safety of rituximab in special types of rheumatoid arthritis. International Journal of Rheumatic Diseases, 2023; 26(11): 2240–2247.
TOURIN O, et al. Pulmonary vasculitis as the first manifestation of rheumatoid arthritis. Respiratory medicine case reports, 2013; 8: 40–42.
VALÉRIO JAE, et al. Vasculitis: Diagnóstico y manejo actual. Medicina interna de México, 1988; 14(4):151-172.
WEYAND CM e GORONZY JJ. Multisystem interactions in the pathogenesis of vasculitis. Current Opinion in Rheumatology, 1997; 9(1): 3-11.
